Lanean...
Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
BACKGROUND: The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment...
Gorde:
| Argitaratua izan da: | BMJ Glob Health |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6570985/ https://ncbi.nlm.nih.gov/pubmed/31263587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgh-2019-001441 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|